FOXP3 and sclerosing cholangitis: Alterations in the intestinal microbiota are a hallmark of IBD.30 Moreover, the intestinal microbiota is known to impact Foxp3+ Treg-cell differentiation and expansion.31 We therefore hypothesised that sclerosing cholangitis may alter the intestinal microbiota, and thus, reduce colitis severity.